Total Payments
$1,986
2024 Payments
$178.25
Companies
6
Transactions
17
Medicare Patients
1,056
Medicare Billing
$155,440
Payment Breakdown by Category
Travel$1,199 (60.4%)
Food & Beverage$526.24 (26.5%)
Consulting$200.00 (10.1%)
Education$61.03 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,199 | 5 | 60.4% |
| Food and Beverage | $526.24 | 10 | 26.5% |
| Consulting Fee | $200.00 | 1 | 10.1% |
| Education | $61.03 | 1 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $1,479 | 11 | $0 (2019) |
| TESARO, Inc. | $261.03 | 2 | $0 (2019) |
| ABBVIE INC. | $125.00 | 1 | $0 (2024) |
| Genentech USA, Inc. | $67.56 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $39.00 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $14.25 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $178.25 | 3 | ABBVIE INC. ($125.00) |
| 2019 | $1,540 | 12 | Merck Sharp & Dohme Corporation ($1,479) |
| 2018 | $267.56 | 2 | TESARO, Inc. ($200.00) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $39.00 | General |
| Category: Oncology | ||||||
| 10/03/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | Cash or cash equivalent | $20.84 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | In-kind items and services | $145.77 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $49.97 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | In-kind items and services | $47.37 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | Cash or cash equivalent | $24.63 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | In-kind items and services | $708.56 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | Cash or cash equivalent | $151.15 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | In-kind items and services | $145.77 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: ONCOLOGY | ||||||
| 02/08/2019 | TESARO, Inc. | ZEJULA (Drug) | Education | In-kind items and services | $61.03 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2018 | TESARO, Inc. | ZEJULA (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: ONCOLOGY | ||||||
| 03/26/2018 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $67.56 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 227 | 246 | $40,660 | $16,956 |
| 2022 | 9 | 213 | 283 | $154,050 | $27,423 |
| 2021 | 11 | 315 | 434 | $661,271 | $63,827 |
| 2020 | 12 | 301 | 404 | $406,765 | $47,233 |
Total Patients
1,056
Total Services
1,367
Medicare Billing
$155,440
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 88 | $13,326 | $5,466 | 41.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 26 | 33 | $7,469 | $3,570 | 47.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 44 | 46 | $4,536 | $2,066 | 45.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 19 | 22 | $3,127 | $1,644 | 52.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $3,919 | $1,400 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 15 | $3,572 | $1,315 | 36.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $2,847 | $962.67 | 33.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2023 | 19 | 20 | $1,864 | $531.88 | 28.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 28 | 74 | $16,189 | $8,115 | 50.1% |
| 58661 | Removal of ovaries and/or tubes using an endoscope | Facility | 2022 | 12 | 12 | $103,191 | $6,699 | 6.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 36 | 36 | $9,773 | $3,714 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 54 | 69 | $6,400 | $3,098 | 48.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 18 | 20 | $2,921 | $1,502 | 51.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $6,965 | $1,502 | 21.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 13 | 14 | $3,388 | $1,111 | 32.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 13 | 13 | $2,341 | $803.16 | 34.3% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2022 | 17 | 22 | $2,444 | $601.61 | 24.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 11 | 12 | $438.00 | $276.40 | 63.1% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 28 | 28 | $308,227 | $18,962 | 6.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 43 | 139 | $27,382 | $16,151 | 59.0% |
| 58661 | Removal of ovaries and/or tubes using an endoscope | Facility | 2021 | 13 | 13 | $99,768 | $6,791 | 6.8% |
| 38570 | Removal of abdominal cavity lymph nodes using an endoscope | Facility | 2021 | 19 | 19 | $137,639 | $4,066 | 3.0% |
| 38900 | Lymph node imaging during surgery | Facility | 2021 | 24 | 24 | $57,236 | $4,039 | 7.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 54 | 70 | $6,149 | $3,530 | 57.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 33 | 33 | $7,968 | $3,505 | 44.0% |
About Dr. Evelyn Fleming, M.D
Dr. Evelyn Fleming, M.D is a Gynecologic Oncology healthcare provider based in Lebanon, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780616219.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Evelyn Fleming, M.D has received a total of $1,986 in payments from pharmaceutical and medical device companies, with $178.25 received in 2024. These payments were reported across 17 transactions from 6 companies. The most common payment nature is "Travel and Lodging" ($1,199).
As a Medicare-enrolled provider, Fleming has provided services to 1,056 Medicare beneficiaries, totaling 1,367 services with total Medicare billing of $155,440. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Gynecologic Oncology, Gynecologic Oncology
- Location Lebanon, NH
- Active Since 07/07/2006
- Last Updated 11/05/2024
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1780616219
Products in Payments
- MK-7339 (Drug) $1,479
- ZEJULA (Drug) $261.03
- ELAHERE (Drug) $125.00
- Avastin (Biological) $67.56
- LYNPARZA (Drug) $39.00
- JEMPERLI (Biological) $14.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Lebanon
Dr. Michael Pearl, M.d, M.D
Gynecologic Oncology — Payments: $324.31
Gynecologic Oncology $324.31
Ivy Wilkinson-Ryan, Md, MD
Gynecologic Oncology — Payments: $133.26
Gynecologic Oncology $133.26
Dr. Loyd West, M.d, M.D
Gynecologic Oncology — Payments: $45.94
Gynecologic Oncology $45.94
Ariel Kredentser, M.d, M.D
Gynecologic Oncology — Payments: $36.00
Gynecologic Oncology $36.00
Christianne Persenaire, M.d, M.D
Gynecologic Oncology
Gynecologic Oncology